MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
833.38%
Quick Ratio
833.38%
Cash Ratio
160.82%
Debt to Asset Ratio
21.48%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Cash and cash equivalents
    • Right-of-use assets
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Convertible preferred stock-Seri...
    • Convertible preferred stock-Seri...
    • Others

Balance Sheets
2026-03-31
Cash and cash equivalents
35,719
Short-term marketable securities
140,030
Prepaid expenses and other current assets
9,352
Total current assets
185,101
Property, plant and equipment, gross
21,663
Less accumulated depreciation
15,107
Property and equipment, net
6,556
Right-of-use assets
17,920
Goodwill
14,072
Intangible asset
160
Long-term marketable securities
0
Other non-current assets
5,261
Total assets
229,070
Accounts payable
8,219
Accrued expenses and other current liabilities
8,618
Lease liabilities, current
5,374
Total current liabilities
22,211
Contingent consideration and warrant liability
6,242
Lease liabilities, non-current
20,753
Total liabilities
49,206
Convertible preferred stock-Series APreferred Stock
216,503
Convertible preferred stock-Series BPreferred Stock
167,765
Convertible preferred stock-Series CPreferred Stock
123,259
Convertible preferred stock-Series DPreferred Stock
196,031
Additional paid-in capital
82,854
Accumulated deficit
-606,401
Accumulated other comprehensive income (loss)
-147
Total stockholders deficit
-523,694
Total liabilities, convertible preferred stock, and stockholders deficit
229,070
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$140,030K Cash and cashequivalents$35,719K Prepaid expenses andother current assets$9,352K Property, plant andequipment, gross$21,663K Total current assets$185,101K Right-of-use assets$17,920K Goodwill$14,072K Property and equipment,net$6,556K Other non-currentassets$5,261K Intangible asset$160K Less accumulateddepreciation$15,107K Total assets$229,070K Accumulated deficit-$606,401K Accumulated othercomprehensive income (loss)-$147K Total liabilities,convertible preferred...$229,070K Total stockholdersdeficit-$523,694K Additional paid-in capital$82,854K Convertible preferredstock-Series APreferred...$216,503K Convertible preferredstock-Series DPreferred...$196,031K Convertible preferredstock-Series BPreferred...$167,765K Convertible preferredstock-Series CPreferred...$123,259K Total liabilities$49,206K Total currentliabilities$22,211K Lease liabilities,non-current$20,753K Contingent considerationand warrant...$6,242K Accrued expenses andother current...$8,618K Accounts payable$8,219K Lease liabilities,current$5,374K

Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics, Inc. (ODTX)